Advanced Parenteral Drug Delivery Devices Market Analysis - Global Industry Size, Share, Trends and Forecast, 2014 - 2024

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC183

Drug delivery devices enable pharmaceutical manufacturers to differentiate their new drugs from already existing products, thereby providing ways for extending patent protection, as well as discover novel treatments. Parenteral drug administration is among the most common route of drug delivery and the major advantage associated with it is high bioavailability of the active pharmaceutical ingredient. Currently, parenteral drug delivery devices constitute the major share of the global drug delivery devices market.

Factors such as increasing usherance of novel biological products and biosimilar are leading to the development of advanced parenteral drug delivery devices for effective delivery of these products. In the drug market, polymer-encapsulated medicines, hormones and central nervous system agents are gaining importance that further requires parenteral drug delivery. Also, wide availability of pen injectors, IV catheters, vial bag infusion systems and retractable pre-fillable syringes will lead to increased market share of these parenteral drug delivery devices as they provide advantages of infection prevention.

The increasing prevalence of chronic disorders such as diabetes, cardiovascular diseases and cancer, growing demand for self-administration and home healthcare devices; the rising incidence of chronic diseases such as cardiovascular diseases, diabetes, and cancer; the growing focus on pediatric and geriatric patients; and the increasing demand for minimally invasive surgeries are other factors contributing to growth in the drug delivery market. In addition, pharmaceutical companies are increasingly adopting drug delivery technologies to differentiate their products in the highly competitive environment.

The global advanced parenteral drug delivery devices market is segmented by applications, products, and geography. On the basis of products, the global advanced parenteral drug delivery devices market is classified into IV catheters, pre-fillable syringes, hypodermic syringes, injector cartridges, and other parenteral delivery devices. In addition, on the basis of applications, the global advanced parenteral drug delivery devices market is bifurcated as central nervous system agents, hormones & related agents, respiratory agents, gastrointestinal agents, anti-infective agents, cardiovascular agents, genito-urinary agents, and nutritional agents.

The global advanced parenteral drug delivery devices market is segmented by region into Asia-Pacific (APAC), Europe, North America, Latin America, and Middle East and Africa. Factors such as increasing usherance of novel biological products and biosimilar are leading to the development of advanced parenteral drug delivery devices for effective delivery of these products. Also, wide availability of pen injectors, IV catheters, vial bag infusion systems and retractable pre-fillable syringes will lead to the increased market share of these parenteral drug delivery devices as they provide advantages of infection prevention.

North America is analyzed to possess the largest market share in terms of revenue owing to the rising patient awareness levels and increasing acceptance and adoption of high-tech healthcare systems. On the other hand, the European market trails the North American market in terms of revenue, owing to increasing acceptance and adoption of high-tech healthcare systems. The global advanced parenteral drug delivery devices market in Asia-Pacific is analyzed to be the most lucrative market owing to the increasing penetration of advanced healthcare technology and products, and rapidly improving healthcare infrastructure in emerging economies of India and China. Thus, the Asia-Pacific region serves as a great untapped opportunity for key market players in this industry.

The global advanced parenteral drug delivery devices market is highly competitive with respect to pricing and technological advancements. A few of the key players dominating the global advanced parenteral drug delivery devices market include Abbott Laboratories, AptarGroup Incorporated, Amgen Incorporated, AstraZeneca plc, Becton, Dickinson and Company, Baxter International Incorporated, Boston Scientific Corporation, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Novartis AG, Roche Holding Limited, and Pfizer Incorporated, among others.


Related Reports

Cardiovascular & Soft Tissue Repair Patches Market (By Application: Vascular Repair & Reconstruction, Cardiac Repair, Pericardial Repair, Soft Tissue repair, Dural Repair; By Raw Material: ePTFE, Biomaterial and Tissue Engineered Material, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction The report provides analysis of global Cardiovascular & Soft Tissue Repair Patches market for the period 2016-2026, wherein 2019 to 2026 is the forecast period and 2017 is considered as the base year. According to Acumen Research and Consulting, the global Cardiovascular & Soft Tissue Repair Patches market is expected to grow at noteworthy CAGR around 8 % throughout the forecas

Virus Filtration Market (By Product Type: Virus Filters & Filtration Systems, Kits & Reagents, Services; By Application: Biological [Blood & Blood Products, Tissue & Tissue Products, Vaccines & Therapeutics, Cellular & Gene Therapy Products, Stem Cell Products], Medical Devices, Water Purification, Air Purification; By End-user: Pharmaceutical and Biotechnology Companies, Contract Research Organization, Medical Devices Companies) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Virus filtration are mainly used to maintain a pathogen such as bacteria, virus, and microbe’s free environment. Presence of pathogens in labs, and biotechnology industries lead to the contamination of water, air, and biotheraputics. Virus filtration maintains the environment and products safety. It also ensures that the products manufactured are of high grade. The market research study on “Virus Filtration Market

Alopecia Market (By Disease Type: Alopecia Areata, Androgenetic Alopecia; By End Users: Homecare Settings, Dermatology Clinics; By Distribution Channel: Prescriptions, OTC) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Alopecia refers to loss of hair from parts of the head or body. Sedentary lifestyle, and unhealthy diets is leading loss of hair among masses. Hormonal miss proportion and aging contribute to rising cases of hair loss. Overall rise in geriatric population and rising awareness and preference for surgical hair transplants and other such treatments is also a positive influence for the global market in the forecast period.

Parenteral Nutrition Market (By Nutrient Type: Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins & Minerals) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction: The global parenteral nutrition market size estimated at nearly USD 8.36 billion by 2026. The global parenteral nutrition market is likely to expand at a CAGR of more than 5.9% from 2018 to 2026. Market Dynamics Presence of a large number of malnourished childre

Medical Billing Outsourcing Market (By Component: In-House, Outsourced; By Service: Back-End, Middle-End, Front-End; By End-Use: Physician Clinics, Hospitals, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The method of outsourcing the billing strategy for medicinal treatment is known as billing. Medical billing outsourcing helps medicinal houses and emergency clinics to concentrate just on therapeutic treatment and administrations. These aides in streamlining the intricate accumulation procedure to defeat nonstop decreases in repayments to fulfill HIPPA act. The report

Cart Summary